M&A
confidence high
sentiment positive
materiality 0.70
HSR waiting period expires for Lilly's acquisition of Centessa; condition satisfied
Centessa Pharmaceuticals plc
- Hart-Scott-Rodino waiting period expired at 11:59 p.m. on May 21, 2026, clearing antitrust review.
- Acquisition of Centessa by Eli Lilly announced March 31, 2026; remains subject to shareholder vote and court sanction.
- Proxy statement filed May 7, 2026; shareholders urged to vote on the scheme of arrangement.
- Closing requires approval by Centessa shareholders and sanction by High Court of Justice of England and Wales.
Featured in Daily 8-K Digest
Selected #6 for 2026-05-22.
Read digest